Financial PerformanceThe company reported FFO numbers slightly lower than consensus numbers.
Target Price AdjustmentThe analyst has lowered the target price to $29 due to a lower NAV/share estimate following the NOI miss in the fourth quarter, reflecting a downward revision in the company's valuation.
Tenant DepartureFormer No.3 tenant, GenesisCare, was a tenant in seven CHCT properties and its departure presents a challenge, although the company has met substantially all of its lease payment obligations.